QA: Amicus Therapeutics INC in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178879_2013_Amicus_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Large missing amount for aggregate "Revenues" added to remainder. industry.us_generic {'missing_ratio': 0.8879913506834505, 'aggregate_val': 122238000, 'exp_sum': 64745000, 'exp_to_value': {'remainder_Revenues': 64745000}}

Graph

Absolute values for 0001178879, Amicus Therapeutics INC

  xvar xval
0 AssetsCurrent 104,617,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 5,029,000
3 remainder_Assets 442,000
4 LiabilitiesCurrent 9,243,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 19,364,000
9 ResearchAndDevelopmentExpense 50,273,000
10 remainder_Expenses -2,104,000
11 remainder_Revenues 18,411,000
12 remainder_NetIncome 337,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 110,088,000
1 Liabilities 9,243,000
2 Expenses 67,533,000
3 Revenues 18,411,000
4 StockholdersEquity 100,845,000
5 NetIncome -48,785,000
6 ComprehensiveNetIncome -48,785,000
7 BaseVar 102,806,000
8 EconomicCapitalRatiobeforeLimitedLiability 2.87
9 EconomicCapitalRatio 3.60

Edgar->Model Mapping

Feature Distribution

Change over Time